Splenic and immune alterations of the Sparc-null mouse accompany a lack of immune response
暂无分享,去创建一个
C. Miller | E. Mouzon | R. C. Hawley | J. Koblinski | N. Lemke | S. Rempel | K. Bobbitt | J. Gutiérrez | S. VanOsdol | W. Golembieski | C. Schultz | R. C. Hawley | L. R. Schultz | J. A. Gutierrez | C. Miller | S A Rempel | K R Bobbitt | L. Schultz
[1] R. Weissleder,et al. SPARC is a VCAM‐1 counter‐ligand that mediates leukocyte transmigration , 2007, Journal of leukocyte biology.
[2] D. Ginzinger,et al. Differential zonal expression and adrenocorticotropin regulation of secreted protein acidic and rich in cysteine (SPARC), a matricellular protein, in the midgestation human fetal adrenal gland: implications for adrenal development. , 2006, The Journal of clinical endocrinology and metabolism.
[3] S. Goerdt,et al. Stabilin-1, a homeostatic scavenger receptor with multiple functions , 2006, Journal of cellular and molecular medicine.
[4] S. Goerdt,et al. Novel Function of Alternatively Activated Macrophages: Stabilin-1-Mediated Clearance of SPARC1 , 2006, The Journal of Immunology.
[5] N. Said,et al. Absence of host-secreted protein acidic and rich in cysteine (SPARC) augments peritoneal ovarian carcinomatosis. , 2005, The American journal of pathology.
[6] G. Weitzer,et al. Parietal endoderm secreted SPARC promotes early cardiomyogenesis in vitro. , 2005, Experimental cell research.
[7] M. Colombo,et al. Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice , 2005, Journal of Cell Science.
[8] Mariano J. Alvarez,et al. Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity. , 2005, Cancer research.
[9] Qiwei Yang,et al. Neuroblastoma Angiogenesis Is Inhibited with a Folded Synthetic Molecule Corresponding to the Epidermal Growth Factor-Like Module of the Follistatin Domain of SPARC , 2004, Cancer Research.
[10] L. Staudt,et al. Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs , 2004, BMC Immunology.
[11] E. Sage,et al. Development of UV-induced squamous cell carcinomas is suppressed in the absence of SPARC. , 2004, The Journal of investigative dermatology.
[12] J. Rutka,et al. International Hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactions. , 2004, Matrix biology : journal of the International Society for Matrix Biology.
[13] E Helene Sage,et al. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis. , 2004, Molecular cancer research : MCR.
[14] J. Kearney,et al. Development and selection of marginal zone B cells , 2004, Immunological reviews.
[15] M. Colombo,et al. Leukocyte, Rather than Tumor-produced SPARC, Determines Stroma and Collagen Type IV Deposition in Mammary Carcinoma , 2003, The Journal of experimental medicine.
[16] I. Kalajzic,et al. Osteonectin-null mutation compromises osteoblast formation, maturation, and survival. , 2003, Endocrinology.
[17] E. Sage,et al. SPARC-null mice exhibit increased adiposity without significant differences in overall body weight , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] R. Brekken,et al. Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM. , 2003, The Journal of clinical investigation.
[19] O. Volpert,et al. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. , 2002, Cancer research.
[20] N. Lemke,et al. Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo. , 2002, Cancer research.
[21] M. Reed,et al. SPARC-null Mice Exhibit Accelerated Cutaneous Wound Closure , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[22] R. Berkowitz,et al. SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells. , 2001, The American journal of pathology.
[23] S. Pillai,et al. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. , 2001, Immunity.
[24] E. Sage,et al. SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. , 2001, The Journal of clinical investigation.
[25] R. Savani,et al. Bleomycin-induced pulmonary injury in mice deficient in SPARC. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[26] J. Schlessinger,et al. Absence of marginal zone B cells in Pyk-2–deficient mice defines their role in the humoral response , 2000, Nature Immunology.
[27] T. Mikkelsen,et al. Increased SPARC expression promotes U87 glioblastoma invasion in vitro , 1999, International Journal of Developmental Neuroscience.
[28] E. Sage,et al. SPARC deficiency leads to early-onset cataractogenesis. , 1998, Investigative ophthalmology & visual science.
[29] T. Mikkelsen,et al. SPARC: a signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas. , 1998, Journal of neuropathology and experimental neurology.
[30] J. Sanes,et al. Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age‐onset cataract formation and disruption of the lens , 1998, The EMBO journal.
[31] O. Podhajcer,et al. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells , 1997, Nature Medicine.
[32] O. Podhajcer,et al. The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma. , 1997, The Journal of investigative dermatology.
[33] K. Oritani,et al. Identification of stromal cell products that interact with pre-B cells , 1996, The Journal of cell biology.
[34] R. Berkowitz,et al. SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells. , 1996, Oncogene.
[35] M. Iruela-Arispe,et al. Distribution of the calcium-binding protein SPARC in tissues of embryonic and adult mice. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[36] N. Harris,et al. A simple method for the isolation of murine peripheral blood lymphocytes. , 1978, Journal of immunological methods.
[37] S. Pillai,et al. Marginal zone B cells. , 2005, Annual review of immunology.